Quercetin inhibits advanced glycation end product formation via chelating metal ions, trapping methylglyoxal, and trapping reactive oxygen species

References

• Benavente-García O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. 2008;56:6185–6205.10.1021/jf8006568
   PubMed Web of Science ®Google Scholar
• Matsuura N, Aradate T, Sasaki C, et al. Screening system for the Maillard reaction inhibitor from natural product extracts. J Health Sci. 2002;48:520–526.10.1248/jhs.48.520
   Web of Science ®Google Scholar
• Matsuda H, Morikawa T, Ando S, et al. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorg Med Chem. 2003;11:1995–2000.10.1016/S0968-0896(03)00067-1
   PubMed Web of Science ®Google Scholar
• Wu CH, Yen G. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem. 2005;53:3167–3173.10.1021/jf048550u
   PubMed Web of Science ®Google Scholar
• Sang S, Shao X, Bai N, et al. Tea polyphenol (−)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chem Res Toxicol. 2007;20:1862–1870.10.1021/tx700190s
   PubMed Web of Science ®Google Scholar
• Shao X, Bai N, He K, et al. Apple polyphenols, phloretin and phloridzin: new trapping agents of reactive dicarbonyl species. Chem Res Toxicol. 2008;21:2042–2050.10.1021/tx800227v
   PubMed Web of Science ®Google Scholar
• Lv L, Shao X, Chen H, et al. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol. 2011;24:579–586.10.1021/tx100457h
   PubMed Web of Science ®Google Scholar
• Li D, Mitsuhashi S, Ubukata M. Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation. Pharm Biol. 2012;50:1531–1535.10.3109/13880209.2012.694106
   PubMed Web of Science ®Google Scholar
• Li D, Shigetomi K, Mitsuhashi S, et al. Maillard reaction inhibitors produced by Paecilomyces sp. Biosci Biotechnol Biochem. 2013;77:2499–2501.10.1271/bbb.130567
   PubMed Web of Science ®Google Scholar
• Li XL, Zheng T, Sang S, et al. Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal. J Agric Food Chem. 2014;62:12152–12158.10.1021/jf504132x
   PubMed Web of Science ®Google Scholar
• Matsuura N, Aradate T, Kurosaka C, et al. 2014. Potent protein glycation inhibition of plantagoside in Plantago major seeds. BioMed Res Int. 2014;2014. ID 208539. Available from http://dx.doi.org/10.1155/2014/208539.
   Web of Science ®Google Scholar
• Shao X, Chen H, Zhu Y, et al. Essential structural requirements and additive effects for flavonoids to scavenge methylglyoxal. J Agric Food Chem. 2014;62:3202–3210.10.1021/jf500204s
   PubMed Web of Science ®Google Scholar
• Yoon SR, Shim SM. Inhibitory effect of polyphenols in Houttuynia cordata on advanced glycation end-products (AGEs) by trapping methylglyoxal. LWT-Food Sci Technol. 2014;61:158–163.
   Web of Science ®Google Scholar
• Lo CY, Li S, Tan D, et al. Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions. Mol Nutr Food Res. 2006;50:1118–1128.10.1002/(ISSN)1613-4133
   PubMed Web of Science ®Google Scholar
• Mira L, Fernadez MT, Santos M, et al. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radical Res. 2002;36:1199–1208.10.1080/1071576021000016463
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen C, Shi H, et al. Curcumin is a biologically active copper chelator with antitumor activity. Phytomedicine. 2016;23:1–8.10.1016/j.phymed.2015.11.005
   PubMed Web of Science ®Google Scholar
• Vistoli G, De Maddis D, Cipak A, et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Res. 2013;47:3–27.10.3109/10715762.2013.815348
   PubMed Web of Science ®Google Scholar
• Han C, Lu Y, Wei Y, et al. D-ribose induces cellular protein glycation and impairs mouse spatial cognition. PLoS One. 2011;6:e24623.10.1371/journal.pone.0024623
   PubMed Web of Science ®Google Scholar
• Ghosh S, Pandey NK, Roy AS, et al. Prolonged glycation of hen egg white lysozyme generates non amyloidal structures. PLoS One. 2013;8:e74336.10.1371/journal.pone.0074336
   PubMed Web of Science ®Google Scholar
• Luckey TD, Venugopal B. Metal toxicity in mammals. Vol. 1, Physiologic and chemical basis for metal toxicity. New York (NY): Springer; 1977.
   Google Scholar
• Symons MCR, Benbow JA, Pelmore H. Study of calcium ion binding to D-ribose in aqueous solutions using hydroxy-proton resonance shifts. J Chem Soc Faraday Trans 1. 1982;78:3671–3677.10.1039/f19827803671
   Google Scholar
• Ye Y, Liu Q, Wang J. Influence of saccharides chelating agent on particle size and magnetic properties of Co2 Z hexaferrite synthesized by sol–gel method. J Sol–Gel Sci Technol. 2011;60:41–47.10.1007/s10971-011-2548-y
   Web of Science ®Google Scholar
• Di Costanzo L, Flores LV, Christianson DW. Stereochemistry of guanidine-metal interactions: Implications for L-arginine-metal interactions in protein structure and function. Proteins. 2006;65:637–642.10.1002/prot.v65:3
   PubMed Web of Science ®Google Scholar
• Gold MH, Youngs HL, Sollewijn G, et al. In: Sigel A, Sigel H, editors. Metal ions in biological systems: manganese and its role in biological processes. Vol. 37, New York (NY): Marcel Dekker, Inc; 2000. p. 559–586.
   Google Scholar
• Shamsi FA, Partal A, Sady C, et al. Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes. J Biol Chem. 1998;273:6928–6936.10.1074/jbc.273.12.6928
   PubMed Web of Science ®Google Scholar
• Beisswenger P, Howell S, Nelson R, et al. α-Oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans. 2003;31:1358–1363.10.1042/bst0311358
   PubMed Web of Science ®Google Scholar
• Kilhovd BK, Juutilainen A, Lehto S, et al. Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women. Atherosclerosis. 2009;205:590–594.10.1016/j.atherosclerosis.2008.12.041
   PubMed Web of Science ®Google Scholar
• Thomas M, Baynes J, Thorpe S, et al. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005;6:453–474.10.2174/1389450054021873
   PubMed Web of Science ®Google Scholar
• Cervantes-Laurean D, Schramm DD, Jacobson EL, et al. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem. 2006;17:531–540.10.1016/j.jnutbio.2005.10.002
   PubMed Web of Science ®Google Scholar
• Inai M, Miura Y, Honda S, et al. Metmyoglobin reduction by polyphenols and mechanism of the conversion of metmyoglobin to oxymyoglobin by quercetin. J Agric Food Chem. 2014;62:893–901.10.1021/jf404357h
   PubMed Web of Science ®Google Scholar
• Nagamatsu R, Mitsuhashi S, Shigetomi K, et al. Cleavage of α-dicarbonyl compounds by terpene hydroperoxide. Biosci Biotechnol Biochem. 2012;76:1904–1908.10.1271/bbb.120378
   PubMed Web of Science ®Google Scholar
• Kasprzak MM, Erxleben A, Ochocki J. Properties and applications of flavonoid metal complexes. RSC Adv. 2015;5:45853–45877.10.1039/C5RA05069C
   Web of Science ®Google Scholar
• Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol Biol. 2006;54:405–419.10.1016/j.patbio.2006.07.006
   PubMed Web of Science ®Google Scholar
• Aguirre L, Arias N, Macarulla MT, et al. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J. 2011;4:189–198.
   Google Scholar
• Thomas MC, Baynes JW, Thorpe SR, et al. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005;6:453–474.10.2174/1389450054021873
   PubMed Web of Science ®Google Scholar
• Webster J, Urban C, Berbaum K, et al. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotoxic Res. 2005;7:95–101.10.1007/BF03033780
   PubMed Web of Science ®Google Scholar
• Price DL, Rhett PM, Thorpe SR, et al. Chelating activity of advanced glycation end-product inhibitors. J Biol Chem. 2001;276:48967–48972.10.1074/jbc.M108196200
   PubMed Web of Science ®Google Scholar
• Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of glycation processes. Diabetes Metab. 2003;29:6S95–6S103.
   PubMed Web of Science ®Google Scholar
• Beisswenger PJ, Howell SK, Touchette AD, et al. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes. 1999;48:198–202.10.2337/diabetes.48.1.198
   PubMed Web of Science ®Google Scholar
• Nagaraj RH. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch Biochem Biophys. 2002;402:110–119.10.1016/S0003-9861(02)00067-X
   PubMed Web of Science ®Google Scholar
• Voziyan PA, Metz TO, Baynes JW, et al. A post-amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem. 2002;277:3397–3403.10.1074/jbc.M109935200
   PubMed Web of Science ®Google Scholar
• Reddy VP, Zhu X, Perry G, et al. Oxidative stress in diabetes and Alzheimer’s disease. J Alzheimers Dis. 2009;16:763–774.
   PubMed Web of Science ®Google Scholar
• Jahan H, Choudhary MI. Glycation, carbonyl stress and AGEs inhibitors: a patent review. Expert Opin Ther Pat. 2015;25:1267–1284.
   PubMed Web of Science ®Google Scholar